SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

TOSHI

TOSHI is trending as community members rally behind rumors of an AI-driven utility pivot and upcoming partnership announcements, which many believe will spark a breakout. The community remains focused on aggressive accumulation during consolidation, viewing the current price action as a coiled spring before a potential upward trend.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO) is trending as investors focus on its role in the AI infrastructure space, with the community actively discussing its native integration into the Solana ecosystem and its potential as a decentralized alternative to traditional cloud computing giants. While some investors remain cautious about governance and centralization concerns following recent subnet volatility, many are using the current price action as an opportunity for accumulation, viewing it as a long-term play on the convergence of artificial intelligence and blockchain technology.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently attracting significant attention due to its ongoing Phase 3 success with lonvoguran ziclumeran for hereditary angioedema and the company's recent equity offering, which has sparked intense debate among retail investors regarding dilution and potential short-term volatility. The community is actively discussing the stock's high short interest and institutional accumulation, with many shareholders maintaining a bullish long-term perspective on the potential of the company's in vivo CRISPR gene-editing platform.

PENGU is the official coin of Pudgy Penguins.  Pudgy Penguins has become the face of crypto with one of the most influential communities in the industry. From large companies wearing the Penguin, to being featured in ETF commercials, to garnering millions of followers and over 100 billion views, the Pengu has become a cultural icon making PENGU the world’s social currency.  PENGU allows for the ever-expanding Pudgy Penguin fanbase and the hundreds of millions of people outside of crypto that see and share the Pudgy Penguin everyday, to join The Huddle. PENGU is a symbol for community, memes, and good vibes.  Believe in Pengu. Believe in the Prophecy.

Pudgy Penguins

Pudgy Penguins is trending as investors actively debate whether the asset's real-world retail presence and new product partnerships justify long-term accumulation despite current market volatility. The community remains sharply divided, with some users loading up on tokens during price dips, while others express frustration over stagnant performance and the broader downturn in the crypto sector.

QuantumScape Corp. engages in developing next-generation solid-state lithium-metal batteries. The company’s next-generation batteries are designed to enable greater energy density, faster charging, and enhanced safety to support the transition away from legacy energy sources toward a lower-carbon future. The company was founded by Jagdeep Singh, Tim Holme, and Fritz B. Prinz in May 2010 and is headquartered in San Jose, CA.

QuantumScape Corp - Ordinary Shares - Class A

QuantumScape Corp

QuantumScape is trending as investors aggressively debate the stock's potential as a critical player in AI data center power infrastructure, with active discussions focusing on the company's silent product development versus broader solid-state battery sector advancements. Community sentiment remains polarized between long-term bulls highlighting strategic partnerships and potential scaling breakthroughs, and skeptical bears frustrated by the timeline of product commercialization and perceived lack of tangible news.

Anthropic

Anthropic is generating significant market buzz as it prepares for a high-profile IPO while navigating a complex regulatory environment and intense competition from rivals like OpenAI. Investors and the community are closely tracking its aggressive infrastructure partnerships, rapid revenue growth, and ongoing high-stakes disputes with government agencies over the responsible deployment of its advanced AI models.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the following segments: Platform and Devices. The Platform segment includes the sale of digital advertising and distribution of streaming services. The Devices segment is involved in the sale of streaming players, Roku-made televisions, smart home products and services, audio products, and related accessories. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku shares are seeing significant volatility following reports that the company is exploring strategic options, including a potential sale, sparking intense debate among investors about the reality of a buyout versus a potential 'pump and dump' rumor. The community is actively weighing the company's long-term value as a dominant streaming platform against short-term price action and the skepticism surrounding unverified acquisition talks.

Swarmer, Inc. is an AI-driven software company, which develops software platforms and AI systems for autonomous swarm control of drones and unmanned vehicles. The firm offers STYX AI Command and Control System, MINAS Autonomy and Collaboration AI, and TRIDENT Embedded Drone Operating System. The company was founded by Alex Fink and Serhii Kuprienko in May 2023 and is headquartered in Austin, TX.

Swarmer Inc.

Swarmer Inc. is trending as investors react to volatile price action and ongoing community debate over its low-float status, with bullish sentiment driven by its role in autonomous drone software and potential defense sector contracts, while skeptics point to high valuations relative to revenue as signs of a potential pump and dump.

Casey's General Stores, Inc. engages in the provision of management and operation of convenience stores and gasoline stations. It provides self-service gasoline, a wide selection of grocery items, and an array of freshly prepared food items. The firm offers food, beverages, tobacco products, health and beauty aids, automotive products, and other non-food items. The company was founded by Donald F. Lamberti in 1968 and is headquartered in Ankeny, IA.

Casey`s General Stores, Inc.

Casey's General Stores, Inc.

Casey's General Stores is surging on investor enthusiasm following a blowout fiscal Q4 earnings report that beat analyst estimates and featured raised guidance, a dividend hike, and an expanded share repurchase program. The community is buzzing over the company's consistent growth as a recession-resistant "compounder," with many traders highlighting the strength of its prepared food and pizza business as a key competitive advantage in the retail landscape.

First Solar, Inc. is a solar technology company, which engages in the provision of solar modules. It is involved in the design, manufacture, and sale of cadmium tellurid (CdTe) solar modules, which convert sunlight into electricity. The company was founded by Michael J. Ahearn in 1999 and is headquartered in Phoenix, AZ.

First Solar Inc

First Solar is experiencing significant volatility driven by market overreactions to Teslas manufacturing ambitions and broader sector concerns regarding Section 232 tariffs. While some traders are bracing for further downside, the community remains deeply divided, with many long-term investors pointing to the company's unique domestic manufacturing advantage and strong backlog as reasons to accumulate during the pullback.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

AbbVie (ABBV) Rises Higher Than Market: Key Facts

AbbVie (ABBV) closed at $227.73 in the latest trading session, marking a +1.32% move from the prior day.

AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend.

Key PointsThe company is expanding both approved and pipeline therapies...

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA/VENCLYXTO (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results

AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA/VENCLYXTO (venetoclax) in First-Line Chronic Lymphocytic Leukemia Highlighting Long-Term Treatment Outcomes for Patients: Nine-Year Results AbbVie Presents New Data at EHA 2026 Congress for VENCLEXTA/VENCLYXTO (venetoclax) in First-Line...

Will Skyrizi & Rinvoq Continue to Drive AbbVie's Topline Through 2026?

ABBV's Skyrizi and Rinvoq post strong Q1 growth, lift 2026 sales outlooks and sustain momentum through new indications.

Can Linzess Continue Driving IRWD's Revenue Growth Through 2026?

Ironwood sees Linzess momentum as strong demand, a pediatric expansion and pricing changes are expected to boost revenues and profit in 2026.

Should You Buy ANI Pharmaceuticals at 9.8x Forward Earnings?

ANIP trades at 9.75x forward earnings after raising 2026 guidance, but investors must weigh Cortrophin-led growth against competition and customer concentration.

ANI Pharmaceuticals Targets Acute Gout With Cortrophin Push

ANIP expands Cortrophin into acute gout flares with a 90-person sales force as investors watch adoption, spending and 2026 milestones.

ANIP Pharmaceuticals' Cortrophin Gel Drives 2026 Growth

ANIP bets on Cortrophin Gel to power 2026 growth as rare disease sales become the majority of revenues. What must keep working?

Morgan Stanley, Shake Shack, Cboe Global Markets And A Health Care Stock On CNBC's 'Final Trades'

Joshua Brown is still bullish on Shake Shack, while Malcolm Ethridge recommends Morgan Stanley and Jim Lebenthal picks AbbVie Inc. as their final trades.read more...

What's Driving Amneal's 2026 Growth Outlook?

AMRX's 2026 outlook is driven by higher profit expectations, a steady launch cadence, and growth from complex generics, injectables, and specialty brands.

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders such as Parkinson’s disease, metabolic disorders, including thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

ABBV Stock Gains On Winning FDA Approval For Rare Blood Cancer Drug

Equity

Bearish Sentiment

Track ABBV stock price, charts, news and real-time market activity on Stocktwits. Join the ABBV message board to follow investor discussions, retail trader sentiment, bullish and bearish signals around AbbVie Inc stock.

ABBVAbbvie Inc

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest ABBV News